[1]盖银玲,王媛媛,杨小春,等.芪实益肾方联合缬沙坦治疗慢性肾小球肾炎的疗效及对炎症因子、肾纤维化指标的影响[J].西部中医药,2022,35(05):119-123.[doi:10.12174/j.issn.2096-9600.2022.05.27]
 GAI Yinling,WANG Yuanyuan,YANG Xiaochun,et al.Clinical Effects of Qishi Benefiting-kidney Prescription in Combination with Valsartan in the Treatment of Chronic Glomerulonephritis and Its Influence on Inflammatory Factors and Renal Fibrosis Indexes[J].Western Journal of Traditional Chinese Medicine,2022,35(05):119-123.[doi:10.12174/j.issn.2096-9600.2022.05.27]
点击复制

芪实益肾方联合缬沙坦治疗慢性肾小球肾炎的疗效及对炎症因子、肾纤维化指标的影响
分享到:

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
35
期数:
2022年05期
页码:
119-123
栏目:
衷中参西
出版日期:
2022-05-15

文章信息/Info

Title:
Clinical Effects of Qishi Benefiting-kidney Prescription in Combination with Valsartan in the Treatment of Chronic Glomerulonephritis and Its Influence on Inflammatory Factors and Renal Fibrosis Indexes
作者:
盖银玲1 王媛媛2 杨小春1 朱莉萍1 陈妍1
1.河北港口集团有限公司港口医院血液透析科,河北 秦皇岛 066000
2.河北省秦皇岛市军工医院
Author(s):
GAI Yinling1 WANG Yuanyuan2 YANG Xiaochun1 ZHU Liping1 CHEN Yan1
1.Hemodialysis Department, Port Hospital of Hebei Port Group Co., LTD, Qinhuangdao 066000, China
2.Hebei Provincial Military Hospital
关键词:
慢性肾小球肾炎炎症因子肾纤维化芪实益肾方缬沙坦
Keywords:
CGNinflammatory factorsrenal fibrosisbenefiting-kidney prescriptionvalsartan
分类号:
R692.7
DOI:
10.12174/j.issn.2096-9600.2022.05.27
文献标志码:
B
摘要:
目的探讨芪实益肾方联合缬沙坦治疗慢性肾小球肾炎(chronic glomerulonephritis,CGN)的疗效及对炎症因子、肾纤维化指标的影响。 方法将CGN患者104例按照随机数字表法分为两组各52例,对照组口服缬沙坦,治疗组口服芪实益肾方与缬沙坦,疗程均为8周。比较两组患者治疗前后中医证候评分、肾功能指标、炎症因子和肾纤维化指标以及总有效率。 结果治疗后治疗组主症、次症评分均低于对照组(P<0.01),血肌酐(serum creatinine,Scr)、尿素氮(blood urea nitrogen,BUN)和24 h尿蛋白定量(24 Upro)均低于对照组(P<0.01);血清核转录因子κB(nuclear factor-κB,NF-κB)、白细胞介素6(interleukin-6,IL-6)、肿瘤坏死因子α(tumor necrosis factor-α,TNF-α)、转化生长因子β1(transforming growth factor-β1,TGF-β1)、金属蛋白酶组织抑制因子1(tissue inhibitor of metalloproteinase-1,TIMP-1)和纤维连接蛋白(fibronectin,FN)水平均低于对照组(P<0.01),白细胞介素10(interleukin-10,IL-10)水平升高,但低于对照组(P<0.01),总有效率高于对照组(P<0.05)。 结论芪实益肾方联合缬沙坦可减轻CGN患者炎症损伤和肾组织纤维化,保护肾功能,改善患者中医证候,效果优于缬沙坦。
Abstract:
ObjectiveTo survey curative effects of Qishi benefiting-kidney prescription and valsartan in treating CGN and its influence on inflammatory factors and renal fibrosis indexes. MethodsA total of 104 CGN patients were divided into two groups according to random number table method, with 52 cases in each group, the control group adopted oral valsartan, and the treatment group took Qishi benefiting-kidney prescription and valsartan, the course was eight weeks. To compare TCM syndrome scores, renal function indexes, inflammatory factors, renal fibrosis indexes, total effective rate between both groups before and after treating. ResultsAfter the treatment, the treatment group was lower than the control group in the scores of the main symptoms and secondary symptoms (P<0.01), the levels of Scr, BUN, 24Upro of the treatment group were lower than these of the control group (P<0.01); the levels of NF-κB, IL-6, TNF-α, TGF-β1, TIMP-1 and FN were lower than these of the control group (P<0.01), the level of IL-10 was raised, but lower than that of the control group (P<0.01), total effective rate was higher than that of the control group (P<0.05). ConclusionQishi benefiting-kidney prescription and valsartan could relieve inflammatory injury and renal fibrosis, protect renal function, improve the patients’ TCM syndromes, and its effects superior to these of valsartan.

相似文献/References:

[1]吴玥露,孔薇△.白细胞介素-6在慢性肾小球肾炎中的作用研究[J].西部中医药,2012,25(11):113.
 WU Yue-lu,KONG Wei.Effects of Interleukin-6 on Chronic Glomerulonephritis[J].Western Journal of Traditional Chinese Medicine,2012,25(05):113.
[2]吴志科.中西药物联合治疗术后炎性肠梗阻40例[J].西部中医药,2013,26(09):10.
 WU Zhike.Treatment for 40 Cases of Postoperative Inflammatory Ileus with Integrative Medicine[J].Western Journal of Traditional Chinese Medicine,2013,26(05):10.
[3]李树纲,柴守华,高新艳,等.黄芪煎剂联合丹红注射液治疗慢性肾炎临床观察[J].西部中医药,2013,26(07):71.
 LI Shugang,CHAI Shouhua,GAO Xinyan,et al.On Clinical Efficacy of HuangQi Decoction and DanHong Injection for Chronic Glomerulonephritis[J].Western Journal of Traditional Chinese Medicine,2013,26(05):71.
[4]燕忠生,魏千程,李俊,等.三种不同功效中药注射制剂治疗放射性肺炎的实验研究[J].西部中医药,2014,27(03):36.
 YAN Zhongsheng,WEI Qiancheng,LI Jun,et al.Experimental Study on Treating Radiation Pneumonitis by Three Kinds of Different Herbal Injections[J].Western Journal of Traditional Chinese Medicine,2014,27(05):36.
[5]张永科,马天寿.小柴胡汤联合多靶点激素治疗肾病综合征60例[J].西部中医药,2014,27(10):120.
[6]写国斌,展存丽,张军.眩晕康汤联合倍他司汀治疗无痛性心绞痛99例[J].西部中医药,2016,29(02):110.
 XIE Guobin,ZHAN Cunli,ZHANG Jun.XuanYun Kang Decoction Combined with Betahistine in Treating 99 Cases of Stable Angina Pectoris[J].Western Journal of Traditional Chinese Medicine,2016,29(05):110.
[7]解鑫隆,徐朝军△,尹晓清,等.醒脑静辅助奥氮平治疗主动脉夹层腔内隔绝术后谵妄45例[J].西部中医药,2018,31(10):79.
 XIE Xinlong,XU Chaojun,YIN Xiaoqing,et al.Treating 45 Cases of Delirium after the EVGE for Aortic Dissection by XingNaoJing Injection as AT and Olanzapine[J].Western Journal of Traditional Chinese Medicine,2018,31(05):79.
[8]邢艳梅.妇炎宁汤联合抗生素治疗慢性盆腔炎52例[J].西部中医药,2018,31(10):97.
 XING Yanmei.FuYanNing Decoction and Antibiotics in Treating 52 Cases of Chronic Pelvic Inflammation[J].Western Journal of Traditional Chinese Medicine,2018,31(05):97.
[9]余新华,郑汉印,徐丽.透明质酸钠联合六味地黄丸治疗老年膝骨性关节炎50例[J].西部中医药,2017,30(08):120.
 YU Xinhua,ZHENG Hanyin,XU Li.Sodium Hyaluronate Combined with LiuWei DiHuang Pills in Treating 50 Senile Patients with Knee Osteoarthritis[J].Western Journal of Traditional Chinese Medicine,2017,30(05):120.
[10]张靓,赵雷,孙芳园,等.升降散治疗瘀毒内阻型脓毒症的临床研究[J].西部中医药,2017,30(12):45.
 ZHANG Liang,ZHAO Lei,SUN Fangyuan,et al.Clinical Study of ShengJiang Powder in the Treatment of Sepsis of Stasis-Toxin Internal Obstruction Pattern[J].Western Journal of Traditional Chinese Medicine,2017,30(05):45.

备注/Memo

备注/Memo:
盖银玲(1980—),女,硕士学位,主治医师。研究方向:慢性肾脏病、糖尿病肾病的诊治。2019秦皇岛科学技术研究与发展计划项目(201902A140)。
更新日期/Last Update: 2022-06-24